Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.

Immune suppressed organ transplant recipients suffer increased morbidity and mortality from primary cutaneous SCC. We studied tumor microenvironment in transplant-associated SCC (TSCC), immune-competent SCC and normal skin by IHC, IF and RT-PCR on surgical discard. We determined T cell polarization...

Full description

Bibliographic Details
Main Authors: Shali Zhang, Hideki Fujita, Hiroshi Mitsui, Valerie R Yanofsky, Judilyn Fuentes-Duculan, Julia S Pettersen, Mayte Suárez-Fariñas, Juana Gonzalez, Claire Q F Wang, James G Krueger, Diane Felsen, John A Carucci
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3646982?pdf=render
_version_ 1818267054384349184
author Shali Zhang
Hideki Fujita
Hiroshi Mitsui
Valerie R Yanofsky
Judilyn Fuentes-Duculan
Julia S Pettersen
Mayte Suárez-Fariñas
Juana Gonzalez
Claire Q F Wang
James G Krueger
Diane Felsen
John A Carucci
author_facet Shali Zhang
Hideki Fujita
Hiroshi Mitsui
Valerie R Yanofsky
Judilyn Fuentes-Duculan
Julia S Pettersen
Mayte Suárez-Fariñas
Juana Gonzalez
Claire Q F Wang
James G Krueger
Diane Felsen
John A Carucci
author_sort Shali Zhang
collection DOAJ
description Immune suppressed organ transplant recipients suffer increased morbidity and mortality from primary cutaneous SCC. We studied tumor microenvironment in transplant-associated SCC (TSCC), immune-competent SCC and normal skin by IHC, IF and RT-PCR on surgical discard. We determined T cell polarization in TSCC and SCC by intracellular cytokine staining of T cell crawl outs from human skin explants. We studied the effects of IL-22, an inducer of keratinocyte proliferation, on SCC proliferation in vitro. SCC and TSCC are both associated with significantly higher numbers of CD3(+) and CD8(+) T cells compared to normal skin. TSCC showed a higher proportion of Foxp3(+) T regs to CD8(+) T cells compared to SCC and a lower percentage of IFN-γ producing CD4(+) T cells. TSCC, however, had a higher percentage of IL-22 producing CD8(+) T cells compared to SCC. TSCC showed more diffuse Ki67 and IL-22 receptor (IL-22R) expression by IHC. IL-22 induced SCC proliferation in vitro despite serum starvation. Diminished cytotoxic T cell function in TSCC due to decreased CD8/T-reg ratio may permit tumor progression. Increased IL-22 and IL-22R expression could accelerate tumor growth in transplant patients. IL-22 may be an attractive candidate for targeted therapy of SCC without endangering allograft survival.
first_indexed 2024-12-12T20:16:30Z
format Article
id doaj.art-b3892a3378e943149ae755b8acb87271
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T20:16:30Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b3892a3378e943149ae755b8acb872712022-12-22T00:13:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0185e6215410.1371/journal.pone.0062154Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.Shali ZhangHideki FujitaHiroshi MitsuiValerie R YanofskyJudilyn Fuentes-DuculanJulia S PettersenMayte Suárez-FariñasJuana GonzalezClaire Q F WangJames G KruegerDiane FelsenJohn A CarucciImmune suppressed organ transplant recipients suffer increased morbidity and mortality from primary cutaneous SCC. We studied tumor microenvironment in transplant-associated SCC (TSCC), immune-competent SCC and normal skin by IHC, IF and RT-PCR on surgical discard. We determined T cell polarization in TSCC and SCC by intracellular cytokine staining of T cell crawl outs from human skin explants. We studied the effects of IL-22, an inducer of keratinocyte proliferation, on SCC proliferation in vitro. SCC and TSCC are both associated with significantly higher numbers of CD3(+) and CD8(+) T cells compared to normal skin. TSCC showed a higher proportion of Foxp3(+) T regs to CD8(+) T cells compared to SCC and a lower percentage of IFN-γ producing CD4(+) T cells. TSCC, however, had a higher percentage of IL-22 producing CD8(+) T cells compared to SCC. TSCC showed more diffuse Ki67 and IL-22 receptor (IL-22R) expression by IHC. IL-22 induced SCC proliferation in vitro despite serum starvation. Diminished cytotoxic T cell function in TSCC due to decreased CD8/T-reg ratio may permit tumor progression. Increased IL-22 and IL-22R expression could accelerate tumor growth in transplant patients. IL-22 may be an attractive candidate for targeted therapy of SCC without endangering allograft survival.http://europepmc.org/articles/PMC3646982?pdf=render
spellingShingle Shali Zhang
Hideki Fujita
Hiroshi Mitsui
Valerie R Yanofsky
Judilyn Fuentes-Duculan
Julia S Pettersen
Mayte Suárez-Fariñas
Juana Gonzalez
Claire Q F Wang
James G Krueger
Diane Felsen
John A Carucci
Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
PLoS ONE
title Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
title_full Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
title_fullStr Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
title_full_unstemmed Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
title_short Increased Tc22 and Treg/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma.
title_sort increased tc22 and treg cd8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma
url http://europepmc.org/articles/PMC3646982?pdf=render
work_keys_str_mv AT shalizhang increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT hidekifujita increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT hiroshimitsui increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT valerieryanofsky increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT judilynfuentesduculan increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT juliaspettersen increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT maytesuarezfarinas increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT juanagonzalez increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT claireqfwang increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT jamesgkrueger increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT dianefelsen increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma
AT johnacarucci increasedtc22andtregcd8ratiocontributetoaggressivegrowthoftransplantassociatedsquamouscellcarcinoma